H.C. Wainwright Starts Biodesix (BDSX) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel deepen AI capex concerns
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts BDSX Hot Sheet
Price: $23.01 -6.92%
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 44 | New: 9
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 44 | New: 9
Join SI Premium – FREE
H.C. Wainwright analyst Yi Chen initiates coverage on Biodesix (NASDAQ: BDSX) with a Buy rating and a price target of $26.00.
For an analyst ratings summary and ratings history on Biodesix click here. For more ratings news on Biodesix click here.
Shares of Biodesix closed at $15.06 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OPay (OPAY) indicated to open at $17-$19, IPO priced at $16
- DoorDash Inc. (DASH) PT Lowered to $250 at Bernstein SocGen Group
- Eli Lilly (LLY) PT Raised to $1,600 at RBC Capital After an 'Impressive Quarter'
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, H.C. Wainwright, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
